- Home
- NYXH vs RZLT Comparison
NYXH vs RZLT Comparison
Compare NYXH & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- RZLT
- Stock Information
- Founded
- NYXH 2009
- RZLT 2010
- Country
- NYXH Belgium
- RZLT United States
- Employees
- NYXH N/A
- RZLT N/A
- Industry
- NYXH Medical/Dental Instruments
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- NYXH Health Care
- RZLT Health Care
- Exchange
- NYXH Nasdaq
- RZLT Nasdaq
- Market Cap
- NYXH 261.1M
- RZLT 292.0M
- IPO Year
- NYXH 2021
- RZLT N/A
- Fundamental
- Price
- NYXH $10.85
- RZLT $4.87
- Analyst Decision
- NYXH Strong Buy
- RZLT Strong Buy
- Analyst Count
- NYXH 5
- RZLT 8
- Target Price
- NYXH $17.00
- RZLT $11.63
- AVG Volume (30 Days)
- NYXH 64.9K
- RZLT 349.3K
- Earning Date
- NYXH 03-13-2025
- RZLT 02-11-2025
- Dividend Yield
- NYXH N/A
- RZLT N/A
- EPS Growth
- NYXH N/A
- RZLT N/A
- EPS
- NYXH N/A
- RZLT N/A
- Revenue
- NYXH $5,668,079.00
- RZLT N/A
- Revenue This Year
- NYXH $22.93
- RZLT N/A
- Revenue Next Year
- NYXH $411.04
- RZLT N/A
- P/E Ratio
- NYXH N/A
- RZLT N/A
- Revenue Growth
- NYXH 32.65
- RZLT N/A
- 52 Week Low
- NYXH $4.27
- RZLT $0.92
- 52 Week High
- NYXH $20.00
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- NYXH 77.88
- RZLT 49.47
- Support Level
- NYXH $8.86
- RZLT $4.47
- Resistance Level
- NYXH $10.08
- RZLT $4.98
- Average True Range (ATR)
- NYXH 0.60
- RZLT 0.33
- MACD
- NYXH 0.22
- RZLT -0.01
- Stochastic Oscillator
- NYXH 84.81
- RZLT 38.10
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.